R. Chris Rathbun , Pharm.D., BCPS, AQ-ID
Associate Professor
Department of Pharmacy: Clinical and Administrative Sciences
Research Summary
Specialties
Infectious Diseases
Education & Experience
Education
- Bachelor of Science in Chemistry, The University of Minnesota College of Chemistry, Duluth, Minnesota
- Doctor of Pharmacy, The University of Minnesota College of Pharmacy, Minneapolis, Minnesota.
- 1991; recertified 1998, 2005. - Board Certified Pharmacotherapy Specialist (#291148), Board of Pharmaceutical Specialties
- 1999. - Added Qualifications in Infectious Diseases Pharmacotherapy, Board of Pharmaceutical Specialties
Professional Experience
Fellowship in Clinical Pharmacy Sciences, Infectious Diseases, The University of Texas at Austin College of Pharmacy
Honors & Service
1998 Teaching Excellence Award
Selected Publications & Presentations
-
Rathbun RC, Liedtke MD, Lockhart SM, Greenfield RA. HIV infection, Antiretroviral therapy. eMedicine from WebhMD. Updated Feb. 19, 2009. Available at http://www.emedicine.com/med/topic1533218.htm
-
Liedtke M, Rathbun R. Warfarin-antiretroviral drug interactions. Ann Pharmacother 2009; 43: 322-328.
-
Lockhart SM, Rathbun RC, Stephens JR,Baker DC, Drevets DA, Greenfield RA, Salvaggio MR, Vincent S. Cutaneous reactions with tenofovir disoproxil fumarate: A report of 9 cases. AIDS 2007; 21: 1370-1373.
-
Stephens JR, Rathbun RC, Lockhart SM, Greenfield RA. Antiretroviral therapy for human immunodeficiency virus infection. J Okla State Med Assoc 2007; 100: 417-424.
-
Rathbun RC, Farmer KC, Lockhart SM, Stephens JR. Validity of a stage of change instrument in assessing medication adherences in indigent HIV-infected patients. Ann Pharmacother 2007; 41: 208-214.
Current Grants Awarded
-
Abott Labs - The pharmacokinetics of Lopinavir/Ritonavir in combination with Atazanavir in HIV-infected subjects